International Clinical Trial: Cetuximab combined with bevacizumab for adjuvant treatment after radical resection of biliary tract tumors: A single-arm, prospective clinical study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131567) titled 'Cetuximab combined with bevacizumab for adjuvant treatment after radical resection of biliary tract tumors: A single-arm, prospective clinical study' on Sept. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Biliary tract malignancies (BTC)

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-21

Target Sample Size: Experimental group:32;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341414

Published by HT Digital Cont...